BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 34082582)

  • 21. Prevalence and Clinical Features of Community-Acquired Pneumonia Caused by Macrolide-Resistant
    Choi JH; Seong GM; Ko Y; Kim YR; Kim C
    Microb Drug Resist; 2019 May; 25(4):577-581. PubMed ID: 30484744
    [No Abstract]   [Full Text] [Related]  

  • 22. Antibiotic sensitivity of 40 Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant isolates from Beijing, China.
    Zhao F; Lv M; Tao X; Huang H; Zhang B; Zhang Z; Zhang J
    Antimicrob Agents Chemother; 2012 Feb; 56(2):1108-9. PubMed ID: 22106216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficiency of the novel quenching-probe PCR method to detect 23S rRNA mutations in children with Mycoplasma pneumoniae infection.
    Nagita A; Muramatsu H; Hokama M; Takami M; Murakami Y; Funashima Y; Nagasawa Z
    J Microbiol Methods; 2021 Feb; 181():106135. PubMed ID: 33422523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emergence of macrolide-resistant Mycoplasma pneumoniae with a 23S rRNA gene mutation.
    Morozumi M; Hasegawa K; Kobayashi R; Inoue N; Iwata S; Kuroki H; Kawamura N; Nakayama E; Tajima T; Shimizu K; Ubukata K
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2302-6. PubMed ID: 15917525
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Wang X; Li M; Luo M; Luo Q; Kang L; Xie H; Wang Y; Yu X; Li A; Dong M; Huang F; Gong C
    Emerg Microbes Infect; 2022 Dec; 11(1):1508-1517. PubMed ID: 35582916
    [No Abstract]   [Full Text] [Related]  

  • 26. Observational retrospective clinical study on clinical features of macrolide-resistant Mycoplasma pneumoniae pneumonia in Chinese pediatric cases.
    Li P; Wang W; Zhang X; Pan J; Gong L
    Sci Rep; 2024 Mar; 14(1):5632. PubMed ID: 38453960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macrolide resistance of Mycoplasma pneumoniae and its detection rate by real-time PCR in primary and tertiary care hospitals.
    Uh Y; Hong JH; Oh KJ; Cho HM; Park SD; Kim J; Yoon KJ
    Ann Lab Med; 2013 Nov; 33(6):410-4. PubMed ID: 24205489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology of macrolide-resistant Mycoplasma pneumoniae by age distribution in Japan.
    Kawakami N; Namkoong H; Saito F; Ishizaki M; Yamazaki M; Mitamura K
    J Infect Chemother; 2021 Jan; 27(1):45-48. PubMed ID: 32868199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular epidemiology of Mycoplasma pneumoniae pneumonia in children, Wuhan, 2020-2022.
    Xu M; Li Y; Shi Y; Liu H; Tong X; Ma L; Gao J; Du Q; Du H; Liu D; Lu X; Yan Y
    BMC Microbiol; 2024 Jan; 24(1):23. PubMed ID: 38229068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macrolide Resistance in Mycoplasma pneumoniae, Midwestern United States, 2014 to 2021.
    Rothstein TE; Cunningham SA; Rieke RA; Mainella JM; Mutchler MM; Patel R
    Antimicrob Agents Chemother; 2022 Apr; 66(4):e0243221. PubMed ID: 35311520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macrolide-Resistant Mycoplasma pneumoniae in the United States as Determined from a National Surveillance Program.
    Waites KB; Ratliff A; Crabb DM; Xiao L; Qin X; Selvarangan R; Tang YW; Zheng X; Dien Bard J; Hong T; Prichard M; Brooks E; Dallas S; Duffy L; Mixon E; Fowler KB; Atkinson TP
    J Clin Microbiol; 2019 Nov; 57(11):. PubMed ID: 31484701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of macrolide resistance of Mycoplasma pneumoniae in children in Shenzhen, China.
    Ma Z; Zheng Y; Deng J; Ma X; Liu H
    Pediatr Pulmonol; 2014 Jul; 49(7):695-700. PubMed ID: 23861188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of Lightmix Mycoplasma macrolide assay for detection of macrolide-resistant Mycoplasma pneumoniae in pneumonia patients.
    Wagner K; Imkamp F; Pires VP; Keller PM
    Clin Microbiol Infect; 2019 Mar; 25(3):383.e5-383.e7. PubMed ID: 30391582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of GENECUBE Mycoplasma for the detection of macrolide-resistant
    Morinaga Y; Suzuki H; Notake S; Mizusaka T; Uemura K; Otomo S; Oi Y; Ushiki A; Kawabata N; Kameyama K; Morishita E; Uekura Y; Sugiyama A; Kawashima Y; Yanagihara K
    J Med Microbiol; 2020 Dec; 69(12):1346-1350. PubMed ID: 33141009
    [No Abstract]   [Full Text] [Related]  

  • 35. Macrolide resistance and molecular typing of Mycoplasma pneumoniae infections during a 4 year period in Spain.
    Rivaya B; Jordana-Lluch E; Fernández-Rivas G; Molinos S; Campos R; Méndez-Hernández M; Matas L
    J Antimicrob Chemother; 2020 Oct; 75(10):2752-2759. PubMed ID: 32653897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical efficacy of macrolide antibiotics against genetically determined macrolide-resistant Mycoplasma pneumoniae pneumonia in paediatric patients.
    Kawai Y; Miyashita N; Yamaguchi T; Saitoh A; Kondoh E; Fujimoto H; Teranishi H; Inoue M; Wakabayashi T; Akaike H; Ogita S; Kawasaki K; Terada K; Kishi F; Ouchi K
    Respirology; 2012 Feb; 17(2):354-62. PubMed ID: 22077195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple-locus variable-number tandem-repeat analysis (MLVA) of macrolide-susceptible and -resistant Mycoplasma pneumoniae in children in Taiwan.
    Lu CY; Yen TY; Chang LY; Liau YJ; Liu HH; Huang LM
    J Formos Med Assoc; 2020 Oct; 119(10):1539-1545. PubMed ID: 31924377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008-2015.
    Tanaka T; Oishi T; Miyata I; Wakabayashi S; Kono M; Ono S; Kato A; Fukuda Y; Saito A; Kondo E; Teranishi H; Tanaka Y; Wakabayashi T; Akaike H; Ogita S; Ohno N; Nakano T; Terada K; Ouchi K
    Emerg Infect Dis; 2017 Oct; 23(10):1703-1706. PubMed ID: 28930026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular beacon based real-time PCR p1 gene genotyping, macrolide resistance mutation detection and clinical characteristics analysis of Mycoplasma pneumoniae infections in children.
    Li L; Ma J; Guo P; Song X; Li M; Yu Z; Yu Z; Cheng P; Sun H; Zhang W
    BMC Infect Dis; 2022 Sep; 22(1):724. PubMed ID: 36068499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with erythromycin in vitro.
    Okazaki N; Narita M; Yamada S; Izumikawa K; Umetsu M; Kenri T; Sasaki Y; Arakawa Y; Sasaki T
    Microbiol Immunol; 2001; 45(8):617-20. PubMed ID: 11592636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.